1619927-63-7

Basic information

• Product Name: N-(cyano(d₂-methyl))-4-(2-(4-(morpholinophenyl)amino)pyrimidin-4-yl)benzamide
• Synonyms: N-(cyano(d₂-methyl))-4-(2-(4-(morpholinophenyl)amino)pyrimidin-4-yl)benzamide
• CAS NO: 1619927-63-7
• Molecular Weight: 416.451
• Mol File: 1619927-63-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-(cyano(d₂-methyl))-4-(2-(4-(morpholinophenyl)amino)pyrimidin-4-yl)benzamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(cyano(d₂-methyl))-4-(2-(4-(morpholinophenyl)amino)pyrimidin-4-yl)benzamide(1619927-63-7)
• EPA Substance Registry System: N-(cyano(d₂-methyl))-4-(2-(4-(morpholinophenyl)amino)pyrimidin-4-yl)benzamide(1619927-63-7)

Safety Data

• Hazardous Substances Data: 1619927-63-7(Hazardous Substances Data)

Upstream product

• 1026029-33-3 4-(2-chloropyrimidin-4-yl) methyl benzoate 
• 99768-12-4 4-methoxycarbonylphenylboronic acid 
• 100-00-5 4-chlorobenzonitrile 
• 945749-71-3 4-(2-(4-(morpholinophenyl)amino)pyrimidin-4-yl)benzoic acid 
• 2524-67-6 4-morpholino-4-yl-phenylamine 
• 10389-51-2 1-morpholino-4-nitrobenzene 

Relevant articles and documents

DEUTERATED PHENYL AMINO PYRIMIDINE COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING SAME

The present invention relates to a deuterated phenyl amino pyrimidine compound and pharmaceutical composition containing the same. Specifically provided are a deuterated phenyl amino pyrimidine compound as represented by formula (I), and pharmaceutical composition containing the compound, or polymorph, pharmaceutically acceptable salt, hydrate or solvate thereof. The compound of the present invention can treat and/or prevent JAK kinase-related diseases, such as bone marrow proliferative disease, cancer, immunologic diseases and the like.